Yang-Hui Jimmy Yeh

Driven by scientific curiosity, Jimmy is committed to an academic career using molecular biology approaches to solve clinically significant problems. Jimmy received his B.S. in Public Health with research focus on single nucleotide polymorphisms in molecular cancer epidemiology. He received his M.S. in Genetics and Ph.D. in Molecular and Cell Biology at the University of Connecticut, working on the mechanisms of human IGF-I Eb-domain peptide (hEb)-mediated killing of metastatic cancer cells (Experimental Cell Research, 2017). He received his postdoctoral training at Yale University School of Medicine working on the pathogenesis of a viral sequence Sphinx (Slow progressive hidden infections of X origin) as a plausible cause of transmissible spongiform encephalopathies (TSE)(PNAS, 2017).Jimmy joined the Ho lab in November 2017. Using his expertise in molecular biology, viral pathogenesis, cancer biology and cell biology, he studies mechanisms and develops strategies to permanently and irreversibly silence HIV-1. With specific interests in host-HIV-1 interactions, he uses a combination of translational and bioinformatics approach to examine the transcriptional landscape of the HIV-1-infected cells.